Filing Details
- Accession Number:
- 0000947871-13-000520
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-07-17 19:18:09
- Reporting Period:
- 2013-07-15
- Filing Date:
- 2013-07-17
- Accepted Time:
- 2013-07-17 19:18:09
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1326583 | Webmd Health Corp. | WBMD | Services-Business Services, Nec (7389) | 202783228 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1230587 | Md J Mark Adler | 111 Eighth Avenue New York NY 10011 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-07-15 | 597 | $21.29 | 14,037 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-07-15 | 6,600 | $23.61 | 20,637 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-15 | 7,197 | $32.50 | 13,440 | No | 4 | S | Direct | |
Common Stock | Disposition | 2013-07-15 | 12,050 | $32.09 | 1,390 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-07-16 | 3,477 | $21.29 | 4,867 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2013-07-16 | 4,259 | $23.54 | 9,126 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-07-16 | 7,736 | $32.11 | 1,390 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-15 | 597 | $0.00 | 597 | $21.29 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-15 | 6,600 | $0.00 | 6,600 | $23.61 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-16 | 3,477 | $0.00 | 3,477 | $21.29 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-07-16 | 4,259 | $0.00 | 4,259 | $23.54 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
3,477 | 2009-10-23 | 2018-12-10 | No | 4 | M | Direct |
0 | 2018-12-10 | No | 4 | M | Direct | |
0 | 2009-10-23 | 2018-12-10 | No | 4 | M | Direct |
0 | 2019-01-01 | No | 4 | M | Direct |
Footnotes
- The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $32.50 to $32.52 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (1) to this Form 4.
- The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $32.04 to $32.20 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (2) to this Form 4.
- The prices reported in Column 4 are weighted average prices. These shares were sold in multiple transactions at prices ranging from $32.01 to $32.20 inclusive. The reporting person undertakes to provide to WebMD Health Corp., any security holder of WebMD Health Corp., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote (3) to this Form 4.
- 25% of the shares underlying the options vested on each of the first, second, third and fourth anniversary of the date of grant. The date of grant for the options was ten years prior to the expiration date.
- 25% of the shares underlying the option vested on the first anniversary of the grant date and 1/48 of the shares vested monthly thereafter over the next three-year period (fully vested on the 4th anniversary of the grant date). The date of grant for the options was ten years prior to the expiration date.